Dasacad 50mg Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Dasatinib (50mg)
Overview Dasacad 50mg Tablet
Chronic myeloid leukemia (CML) is treated with Dasacad 50mg tablets, particularly in patients unresponsive to or intolerant of alternative leukemia therapies. This medication can be ingested with or without food, but consistent daily timing optimizes effectiveness. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can cause severe adverse effects. Therapeutic benefits might not be immediately apparent, requiring several weeks or months; discontinue only under medical guidance. Common side effects include nausea, vomiting, abdominal discomfort, and skin rash. Increased heart rate and blood pressure fluctuations (high or low) are possible; consult your doctor if this occurs. Regular blood pressure monitoring may be implemented. Avoid antacids within two hours of taking Dasacad. Reduced blood cell counts, increasing infection risk, necessitate routine blood tests. Inform your healthcare provider of all other medications you are taking, as interactions are possible. Dasacad is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or blurred vision develops.
Primary Ingredients of Dasacad 50mg Tablet
The provided text is "undefined," so no rephrasing is possible.
Uses of Dasacad 50mg Tablet
Chronic myelogenous leukemia, a type of blood cancer
Major Benefits of Dasacad 50mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dasacad 50mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dasacad 50mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Dasacad 50mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg Dasacad tablet whole; avoid crushing, chewing, or breaking it. While Dasacad 50mg Tablets can be taken with or without food, consistent timing is recommended.
How Dasacad 50mg Tablet works:
Oncaspar 50mg tablets are a cancer treatment. Their mechanism involves inhibiting the activity of a faulty protein responsible for triggering cancer cell proliferation. This action serves to halt or decelerate the growth of cancerous cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Dasacad 50mg Tablet and alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Dasacad 50mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's inadvisable. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the known hazards. Always seek medical counsel.
Breast feedingUNSAFE
Lactation and Dasacad 50mg tablets are incompatible; the medication presents a potential risk of infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Dasacad 50mg Tablet side effects. Exercise caution while driving, particularly if dizziness or blurred vision occurs after taking Dasacad 50mg Tablet.
KidneySAFE IF PRESCRIBED
Dasacad 50mg tablets appear to be well-tolerated by individuals with kidney impairment. Preliminary evidence indicates dose modification may not be necessary, but physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Dasacad 50mg tablets can be used safely by individuals with hepatic impairment. No alteration of the Dasacad 50mg tablet dosage is advised.
What if you forget to take Dasacad 50mg Tablet :
Omit any missed Dasacad 50mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Dasacad 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently